Cargando…
Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance
Quantitative characterization of evolving tumor resistance under targeted treatment could help identify novel treatment schedules, which may improve the outcome of anti-cancer treatment. In this study, a mathematical model which considers various clonal populations and evolving treatment resistance...
Autores principales: | Yin, Anyue, van Hasselt, Johan G. C., Guchelaar, Henk-Jan, Friberg, Lena E., Moes, Dirk Jan A. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913638/ https://www.ncbi.nlm.nih.gov/pubmed/35273301 http://dx.doi.org/10.1038/s41598-022-08012-7 |
Ejemplares similares
-
Publisher Correction: Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance
por: Yin, Anyue, et al.
Publicado: (2022) -
A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid Tumors
por: Yin, Anyue, et al.
Publicado: (2019) -
Exposure–response analysis of endoxifen serum concentrations in early-breast cancer
por: Sanchez-Spitman, Anabel Beatriz, et al.
Publicado: (2020) -
Assessment of ibrutinib scheduling on leukocyte, lymph node size and blood pressure dynamics in chronic lymphocytic leukemia through pharmacokinetic‐pharmacodynamic models
por: Ibrahim, Eman I. K., et al.
Publicado: (2023) -
Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients
por: Zwart, Tom C., et al.
Publicado: (2020)